Pavia e Ansaldo has longstanding experience in the healthcare and life sciences sector, and it maintains active communication with globally significant regulatory bodies including the European Medicines Agency and the US Food and Drug Administration. The firm is expert in advising major pharmaceutical and biotechnology clients on IP litigation, regulatory, M&A, competition and data protection matters with an international element. Gian Paolo Di Santo leads the firm’s life sciences practice alongside his IP litigation, corporate and regulatory work for leading multinationals in the life sciences industry.
Legal 500 Editorial commentary
Practice head
The lawyer(s) leading their teams.
Gian Paolo Di Santo